Clinical use of a selective culture medium for wild and antibiotic-resistant Propionibacterium acnes.
D000152:Acne Vulgaris / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D002981:Clindamycin / Q000494:pharmacology / Q000627:therapeutic use; D003470:Culture Media; D004352:Drug Resistance, Microbial; D004917:Erythromycin / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005664:Furazolidone / Q000494:pharmacology*; D006801:Humans; D008297:Male; D011425:Propionibacterium acnes / Q000187:drug effects* / Q000302:isolation & purification; D013754:Tetracyclines / Q000494:pharmacology / Q000627:therapeutic use
D003470:Culture Media; D013754:Tetracyclines; D002981:Clindamycin; D005664:Furazolidone; D004917:Erythromycin